1 |
Ambrisentan
💬 | [1] Ambrisentan Ambrisentan | [1] Ambrisentan Ambrisentan | [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
2 |
Ascorbic acid
💬 | [1] Ascorbic acid Ascorbic acid | [2] Ascorbic acid Ascorbic acid; Vitamin C | - | - | [8] 10 10, 97, 192, 206, 210, 211, 212, 298 💬
|
3 |
Bosentan
💬 | [1] Bosentan Bosentan | [2] Bosentan Bosentan; Bosentan monohydrate | [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
4 |
Bosentan
💬 | [1] Bosentan Bosentan | [2] Bosentan Bosentan; Bosentan monohydrate | [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
5 |
Methylprednisolone
💬 | [1] Methylprednisolone Methylprednisolone | [3] Methylprednisolon Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
6 |
Methylprednisolone acetate
💬 | [1] Methylprednisolone Methylprednisolone | [3] Methylprednisolon Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
7 |
Nitrogen
💬 | [1] Nitrogen Nitrogen | [1] Nitrogen Nitrogen | - | - | [5] 5 5, 6, 17, 211, 299 💬
|
8 |
Oxandrolone
💬 | [1] Oxandrolone Oxandrolone | [1] Oxandrolone Oxandrolone | [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [2] 211 211, 285 💬
|
9 |
Oxygen
💬 | [1] Oxygen Oxygen | [1] Oxygen Oxygen | - | - | [13] 22 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
|
10 |
Sildenafil
💬 | [1] Sildenafil Sildenafil | [3] Sildenafil Sildenafil; Sildenafil citrate; Sildenafilo | [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [14] 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
11 |
Sildenafil citrate
💬 | [1] Sildenafil Sildenafil | [3] Sildenafil Sildenafil; Sildenafil citrate; Sildenafilo | [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [14] 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|